$6.95 B
Share price
Change (1 day)
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: $6.95 Billion

As of October 2023 Exelixis has a market cap of $6.95 Billion. This makes Exelixis the world's 1955th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2001 to 2023

End of year Market Cap

Year Market cap Change
2023$6.95 B34.46%
2022$5.17 B-10.54%
2021$5.78 B-7.11%
2020$6.22 B16.3%
2019$5.35 B-9.24%
2018$5.89 B-34.42%
2017$8.99 B108.06%
2016$4.32 B236.22%
2015$1.28 B355.78%
2014$0.28 B-75.06%
2013$1.13 B34.75%
2012$0.83 B30.78%
2011$0.64 B-28.46%
2010$0.89 B12.81%
2009$0.79 B50.04%
2008$0.53 B-41.36%
2007$0.90 B4.63%
2006$0.86 B9.96%
2005$0.78 B10.28%
2004$0.71 B41.74%
2003$0.50 B5.8%
2002$0.47 B-49.09%
2001$0.93 B

End of Day market cap according to different sources

On Sep 30th, 2023 the market cap of Exelixis was reported to be:

$6.95 Billion
by Yahoo Finance info icon info icon
$6.95 Billion
by CompaniesMarketCap info icon info icon
$6.95 Billion
by Nasdaq info icon info icon
$6.95 Billion
by Iex Cloud info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$375.59 B 5,299.13%๐Ÿ‡บ๐Ÿ‡ธ USA
$187.27 B 2,592.06%๐Ÿ‡บ๐Ÿ‡ธ USA
$143.75 B 1,966.52%๐Ÿ‡บ๐Ÿ‡ธ USA
$136.32 B 1,859.63%๐Ÿ‡ซ๐Ÿ‡ท France
$261.23 B 3,655.24%๐Ÿ‡บ๐Ÿ‡ธ USA
$121.25 B 1,642.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$75.34 B 983.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
$0.77 B-88.85%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.52 B-92.50%๐Ÿ‡บ๐Ÿ‡ธ USA